ArticleJournal of cheminformatics2026
A novel approach for enhancing the potency of kinase inhibitors using topological water networks.
Article in Journal of cheminformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Optimizing the potency of kinase inhibitors remains a major challenge due to the structural conservation of kinase binding pockets. While several computational methods have been developed to address this issue, most overlook the crucial role of water molecules within the binding site. Our research aims to address this gap by examining topological water networks (TWNs) within the target protein. We identified specific TWN-derived patterns in kinase binding sites which align with known crystallographic kinase fragments. Our findings reveal the potential of TWNs to significantly improve the identification and optimal placement of promising fragments within protein binding sites. Here, we propose TWN-based fragment growing (TWN-FG) method that enhances kinase inhibitor potency by leveraging the topological characteristics of hydration networks. TWN-FG successfully explains structure-activity relationship (SAR) trends of known kinase inhibitors and has been applied to design and synthesize a potent mixed lineage kinase 1 (MLK1) inhibitor. The source code is available at https://github.com/RgJeoung/TWN-FG to support further research and application.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.